Quantinuum shares have moved sharply since the company’s landmark IPO. After pricing at $60 and climbing as high as $86.79 in the first week of July, QNT has settled near $56.52, sitting below its initial offering price. The recent pullback aligns with broader pressure across quantum computing names, including IONQ. Even so, major institutional backers such as NVDA, JPM, and AMGN continue to hold positions, and a fresh round of bullish analyst coverage followed the end of the IPO quiet period.
Quantinuum operates as a full-stack quantum computing company formed by the merger of Honeywell Quantum Solutions and Cambridge Quantum. Based in Broomfield, Colorado, it develops both hardware and software aimed at enterprise and government uses in areas such as cybersecurity, materials science, pharmaceutical research, financial modeling, and machine learning. Its trapped-ion approach, built on the proprietary QCCD framework, has posted strong fidelity results. The roadmap features the commercially deployed Helios system along with planned Sol and Apollo platforms. Deep backing from HON, NVDA, and JPM gives the company a solid capital position relative to many pure-play peers in this emerging sector. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Several events have shaped the stock’s path in recent weeks. The June 29 expiration of the IPO quiet period brought a wave of new analyst coverage. Rosenblatt Securities set a $155 target, Needham $100, Evercore ISI $98, Mizuho $90, Jefferies $90, Cantor Fitzgerald $90, while J.P. Morgan initiated with Overweight and a $97 target. Morgan Stanley assigned an Equalweight rating and $78 target. In early July, Quantinuum announced a multi-year collaboration with RYCEY, Riverlane, and the University of Edinburgh’s EPCC supercomputing center focused on hybrid quantum-classical workflows for gas turbine fluid-dynamics simulations. The stock fell 9% on the announcement day amid profit-taking. The U.S. Commerce Department’s $2 billion quantum computing initiative, which includes roughly $100 million earmarked for Quantinuum, offers longer-term support. At the same time, Q1 FY2026 results showed revenue of just $5.24 million against a net loss of $136.59 million, underscoring the early stage of commercialization.
Several factors will likely influence QNT through the rest of 2026. Quarterly results will be watched closely for any signs of faster commercial revenue growth, given the company’s sub-$30 million annual run rate and multi-billion-dollar market capitalization. Milestones on the Helios roadmap and progress toward the Apollo architecture will serve as important validation points. Additional government funding, new enterprise wins, and partnership expansions should also move sentiment. The Federal Reserve’s rate path remains a macro consideration for long-duration growth names. Competitive moves from IONQ, QBTS, RGTI, IBM, and GOOGL will continue to shape positioning. With $677 million in cash and equivalents as of March 31, Quantinuum has a reasonable near-term runway, though ongoing cash-burn monitoring will stay important.
When analyzing fast-moving emerging-technology stocks, I often look for data-driven ways to complement fundamental research. Tickeron’s Trending AI Robots page offers a curated view of top-performing AI trading bots drawn from a marketplace of hundreds that actively trade thousands of tickers. These bots vary in strategy, asset focus, holding periods, and risk parameters, helping users identify approaches that align with their own objectives. The Trending section highlights only the most relevant and consistently performing robots, providing a practical look at how automated intelligence can support analysis in sectors like quantum computing. I find it useful to review the list periodically to see which strategies are gaining traction in current market conditions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
QNT saw its Momentum Indicator move below the 0 level on November 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 4 similar instances where the indicator turned negative. In 4 of the 4 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for QNT turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 2 similar instances when the indicator turned negative. In 2 of the 2 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for QNT entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +14.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where QNT advanced for three days, in 9 of 9 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
QNT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.571) is normal, around the industry mean (-1.939). P/E Ratio (-27.402) is within average values for comparable stocks, (9.673). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.843). Dividend Yield (0.000) settles around the average of (0.072) among similar stocks. P/S Ratio (81.967) is also within normal values, averaging (71.334).
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. QNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware